UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
LXP Industrial Trust
LXP
$3.57B
| $5.56M | ﹤0.01% |
135,552
-1,348
| -1% | -$55.6K |
|
1027
Fair Isaac
FICO
$22.5B
| $5.55M | ﹤0.01% |
29,693
+512
| +2% | +$99.9K |
|
|
MDCO
1028
DELISTED
Medicines Co
MDCO
| $5.53M | ﹤0.01% |
289,123
+10,853
| +4% | +$252K |
|
1029
Chemed
CHE
$7.22B
| $5.53M | ﹤0.01% |
19,504
+665
| +4% | +$201K |
|
1030
iShares Core MSCI EAFE ETF
IEFA
$196B
| $5.52M | ﹤0.01% |
100,430
-1,550,141
| -94% | -$90.9M |
|
1031
Guidewire Software
GWRE
$14.2B
| $5.52M | ﹤0.01% |
68,827
-3,551
| -5% | -$310K |
|
1032
Hubbell
HUBB
$27.2B
| $5.52M | ﹤0.01% |
55,541
-669
| -1% | -$73.4K |
|
1033
Quanta Services
PWR
$101B
| $5.49M | ﹤0.01% |
182,257
-5,152
| -3% | -$167K |
|
|
ZEN
1034
DELISTED
ZENDESK INC
ZEN
| $5.44M | ﹤0.01% |
93,250
-3,802
| -4% | -$219K |
|
1035
ICU Medical
ICUI
$4.61B
| $5.43M | ﹤0.01% |
23,630
+7,650
| +48% | +$1.89M |
|
1036
First American
FAF
$7.58B
| $5.42M | ﹤0.01% |
121,369
-16,177
| -12% | -$750K |
|
1037
Urban Edge Properties
UE
$2.73B
| $5.41M | ﹤0.01% |
325,233
-10,439
| -3% | -$206K |
|
1038
Starwood Property Trust
STWD
$6.09B
| $5.38M | ﹤0.01% |
273,072
+28,568
| +12% | +$616K |
|
1039
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| – | – |
0
| – | – |
|
1040
Toll Brothers
TOL
$14.5B
| $5.37M | ﹤0.01% |
163,130
-503,272
| -76% | -$16.2M |
|
|
LEXEA
1041
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $5.36M | ﹤0.01% |
137,083
-10,891
| -7% | -$453K |
|
1042
Agree Realty
ADC
$9.41B
| $5.35M | ﹤0.01% |
90,506
+15,860
| +21% | +$907K |
|
1043
Aecom
ACM
$9.75B
| $5.34M | ﹤0.01% |
201,399
+16,694
| +9% | +$508K |
|
1044
Hexcel
HXL
$7.82B
| $5.3M | ﹤0.01% |
92,367
-3,567
| -4% | -$215K |
|
1045
ASML
ASML
$669B
| $5.29M | ﹤0.01% |
34,014
-6,059
| -15% | -$1.03M |
|
1046
iShares TIPS Bond ETF
TIP
$14.5B
| $5.29M | ﹤0.01% |
48,327
-7,576
| -14% | -$827K |
|
1047
ITT
ITT
$19.1B
| $5.27M | ﹤0.01% |
109,092
-10,207
| -9% | -$539K |
|
1048
Popular Inc
BPOP
$11.1B
| $5.24M | ﹤0.01% |
111,010
-11,929
| -10% | -$615K |
|
1049
Collegium Pharmaceutical
COLL
$956M
| $5.24M | ﹤0.01% |
305,281
+292,781
| +2,342% | +$5.01M |
|
|
ROIC
1050
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $5.23M | ﹤0.01% |
329,506
-14,380
| -4% | -$253K |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.